Clinical Trial Update: Daily Dystonia Practice - A Trial to Investigate NT 201, the Duration of Treatment Effect After One Injection Session and in Long-term Treatment in Cervical Dystonia [Phase 4]

View source ↗

Summary

This Phase 4 trial update reports on NT 201 (incobotulinumtoxinA) for cervical dystonia, examining the duration of effect after a single injection and long-term…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Dystonia

Drugs mentioned

• NT 201

Snippet

Sponsor: Merz Pharmaceuticals GmbH | Conditions: Cervical Dystonia | Phase 4 | Status: COMPLETED